Pharmacological targeting of cell necroptosis/ferroptosis could promote cell adaptive repair and improve fibrosis
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a leading medication for weight management across the United States, including Chicago
doi: 10.1016/S0140-6736(21)00213-0 Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jdar E, Kandler K, Rigas G, Wadden TA, Wharton S
It helps lighten hyperpigmentation, fights acne, and protects your skin from harmful UV rays
"Some of those folks are going to get their hands on anorectic medicine and they're going to be able to drive their hunger into near non-existence," Mr Israetel says